Marchex (MCHX) Cash & Equivalents (2010 - 2026)

Marchex (MCHX) has reported Cash & Equivalents for 16 consecutive years, with $9.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents fell 22.13% year-over-year to $9.9 million; the TTM figure through Dec 2025 stood at $9.9 million (down 22.13% YoY), while the FY2025 annual figure was $9.9 million, down 22.13% from the prior year.
• Cash & Equivalents eased to $9.9 million in Q4 2025 per MCHX's latest filing, from $10.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $28.2 million in Q1 2021 and bottomed at $9.9 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $17.6 million across 5 years, with a median of $14.4 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slipped 10.77% — and 2023, when it slumped 43.1%.
• Marchex's Cash & Equivalents stood at $27.1 million in 2021, then fell by 24.41% to $20.5 million in 2022, then fell by 28.66% to $14.6 million in 2023, then retreated by 12.6% to $12.8 million in 2024, then fell by 22.13% to $9.9 million in 2025.
• Business Quant data shows MCHX's Cash & Equivalents at $9.9 million in Q4 2025, $10.3 million in Q3 2025, and $10.5 million in Q2 2025.